Obesity
Not recruitingEfficacy and Safety of MET097 Once Weekly in People with Overweight or Obesity and Type 2 Diabetes
- Disease:Obesity
- Substances:–
Bulgaria- Participants:18–64 years · 65+ years
- Sponsor:Metsera Inc.
Rare diseases
Investigational molecules
Locations
175 Greenwich Street, 3 World Trade Center, 10007-2439, United States
Metsera Inc. focuses its clinical research on obesity and overweight, with trials centered on body-weight reduction and related metabolic health outcomes.
The sponsor also studies people with type 2 diabetes alongside excess body weight, reflecting interest in conditions where glycaemic control and adiposity are closely linked.
Metsera Inc. runs clinical trials in conditions such as Obesity, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
Bulgaria
BulgariaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.